Understanding COVID-19 Symptoms, Variants, and Testing: Insights for This Winter’s Wave

As COVID-19 and flu cases surge in multiple regions, including 16 state health departments, the CDC highlights the rising respiratory illness trend. Amid this, the new JN.1 variant is driving infections, yet no new or unusual symptoms have been identified so far.

COVID 19 National Emergency [Photo: VerityStream]

Understanding Common Symptoms Amid Respiratory Infections

Experts note that deciphering symptoms caused by different COVID-19 variants is complex due to varied antibodies from vaccinations or prior infections. The CDC mentions that symptoms and severity rely more on an individual’s immunity and health than the specific variant causing the infection.

Survey data from the UK’s health authorities outlines common symptoms observed in the current wave of respiratory infections, including a runny nose, cough, headache, weakness, and sore throat. However, distinguishing symptoms based on specific infections like COVID-19 versus others remains unclear.

Research from the UK suggests that discerning between COVID-19, influenza, and RSV (respiratory syncytial virus) based on symptoms alone is challenging. Previous studies have shown similarities in symptoms between different infections causing respiratory illnesses.

READ ALSO: Are COVID-19 symptoms still the same? What to know about this winter’s JN.1 wave

Updates on COVID-19 Symptoms, Long-Term Effects, and Testing Recommendations in the US

There have been changes in the incidence of loss of taste or smell, which has decreased significantly since the pandemic’s onset. Research also indicates a gradual reduction in the virus’s incubation period, with people falling ill sooner after exposure.

Regarding long-term COVID, prevalence rates seem to have declined, with around 1 in 10 adults experiencing persistent symptoms. However, definitions of long-term COVID vary, and certain symptoms like fatigue, brain fog, and heart palpitations persist in some patients even after six months.

COVID-19 testing recommendations in the US haven’t drastically changed. The FDA advises repeating antigen tests after 48 hours if initial results are negative but symptoms persist. There’s interest in exploring alternative testing methods, such as throat swabbing, to improve accuracy, but these approaches have yet to receive FDA authorization for home use.

READ ALSO: COVID and flu surge could strain hospitals as JN.1 variant grows, CDC warns